Diabetes Multidisciplinary Diagnosis and Treatment Center of No.534 Hospital of the Chinese People's Liberation Army is a specialized and targeted medical elite team established in China to meet the needs of comprehensive prevention and control of diabetes, and the center will provide high-tech, multidisciplinary and team-based comprehensive prevention and treatment services for diabetic patients and their high-risk groups. The diagnosis and treatment programs mainly include: diabetes screening and typing and grading diagnosis and treatment, health education and lifestyle intervention, nutritional balancing treatment, examination and assessment of pancreatic islet function, screening and assessment of chronic complications, especially diabetic eye disease, podiatry, nephropathy, neuropathy, vasculopathy, sexual dysfunction, cardiovascular lesions, cerebrovascular lesions, atherosclerosis, osteoporosis, joints and muscle lesions, and thyroid gland lesions, Gout, hepatobiliary and gastrointestinal lesions for early prevention and medical intervention, diabetic surgery GBP surgery, diabetic intensive care unit, vascular intervention, stem cell therapy, Chinese medicine specialty therapy, rehabilitation and light energy physiotherapy, as well as expert remote consultation center and other services. It gives full play to the efficacy of multidisciplinary, all-round and high-tech treatment and is committed to solving the major difficult problems of diabetes in a one-stop manner.
The center has a technical group of experts in various disciplines and is guided by famous scholars in China. Among them are: Professor Zhang Xinguo, the founder of GBP surgery in China, Director of General Surgery Department of China Armed Police General Hospital, doctoral supervisor, enjoying the State Council's special governmental allowance; Professor Liu Zunyong, the drafter of China's "Outline of Comprehensive Prevention and Control of Diabetes" and the chairman of China's Comprehensive Prevention and Control of Diabetes Working Committee of China CDC; Professor Liu Zunyong, the vice-chairman of Behavioral Medicine of Chinese Medical Association. Chinese Medical Association behavioral medicine, enjoy the State Council special allowance experts, diabetes health education and comprehensive prevention and treatment experts, such as Professor Zhang Ximing, several domestic and foreign diabetes authority experts, the center has a more comprehensive examination, diagnosis, treatment and scientific research capabilities.
The endocrine laboratory of the center is equipped with a full set of endocrine testing equipments such as radioimmunoassay, enzyme immunoassay, biochemistry, chemiluminescence, etc., which can carry out a full set of diabetes specialty tests such as insulin release test, C-peptide release test, T3, T4, TSH, sex hormone, etc. The center has the American dynamic blood glucose monitoring system. The center has a number of advanced testing and treatment equipments such as American dynamic glucose monitoring system, insulin pump, vista ultrasound vascular diagnostic instrument, PAD detector, blood gas circulation therapeutic instrument, radiofrequency ablation therapeutic instrument, airwave power therapeutic instrument and other advanced testing and treatment equipments, as well as advanced operation room and DICU room.
The unique feature of gastric gastric diversion surgery (GBP) is that it changes the physiological flow of food and divides it into two parts of the digestive tract according to whether the food passes through or not: ① food diversion area - the negative phase of the digestive tract regulates the action of the digestive tract, which is not stimulated by food and secretes or synthesizes fewer diabetes-causing factors; ② food flow area - the positive phase of the digestive tract regulates the action of the digestive tract and secretes or synthesizes fewer diabetes-causing factors. Positive phase regulation of the digestive tract, acceptance of incompletely digested food, food stimulation induces increased synthesis and/or secretion of endocrine hormones of intestinal origin, such as glucagon-like peptide-1 (GLP-1), which regulates pancreatic endocrine function through the intestinal - pancreatic islet axis to increase insulin synthesis and/or release, and improve the peripheral tissues to insulin sensitivity. .
The intestinal neuroendocrine theory is doubly favored by academics, that is, the regulation of glucose metabolism by endocrine hormones in the gastrointestinal tract after GBP is one of the main mechanisms of GBP in the treatment of type 2 diabetes mellitus, and the detailed mechanism is as follows: the incompletely digested food stimulates the distal small intestine through the food diversion zone earlier, and through the intestinal - pancreatic islet axis, the intestinal endocrine cell is induced to increase secretion of enteric endocrine hormone; the intestinal endocrine cell increases secretion of enteric endocrine hormone. Enterogenic endocrine hormones act on pancreatic islets to promote regeneration and proliferation of islets and regulate pancreatic endocrine function.